|
1
|
Lagos-Quintana M, Rauhut R, Lendeckel W
and Tuschl T: Identification of novel genes coding for small
expressed RNAs. Science. 294:853–858. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: Are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu CW, Hsiung CA, Lo SS, Hsieh MC, Chen
JH, Li AF, Lui WY and Whang-Peng J: Nodal dissection for patients
with gastric cancer: A randomised controlled trial. Lancet Oncol.
7:309–315. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sharma MR and Schilsky RL: GI cancers in
2010: New standards and a predictive biomarker for adjuvant
therapy. Nat Rev Clin Oncol. 8:70–72. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Smyth EC and Cunningham D: Gastric cancer
in 2012: Defining treatment standards and novel insights into
disease biology. Nat Rev Clin Oncol. 10:73–74. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dassen AE, Lemmens VE, van de Poll-Franse
LV, Creemers GJ, Brenninkmeijer SJ, Lips DJ, Vd Wurff AA, Bosscha K
and Coebergh JW: Trends in incidence, treatment and survival of
gastric adenocarcinoma between 1990 and 2007: A population-based
study in the Netherlands. Eur J Cancer. 46:1101–1110. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
GASTRIC (Global Advanced/Adjuvant Stomach
Tumor Research International Collaboration) Group, . Oba K,
Paoletti X, Bang YJ, Bleiberg H, Burzykowski T, Fuse N, Michiels S,
Morita S, Ohashi Y, et al: Role of chemotherapy for
advanced/recurrent gastric cancer: An individual-patient-data
meta-analysis. Eur J Cancer. 49:1565–1577. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang TH, Yeh CT, Ho JY, Ng KF and Chen TC:
OncomiR miR-96 and miR-182 promote cell proliferation and invasion
through targeting ephrinA5 in hepatocellular carcinoma. Mol
Carcinog. 55:366–375. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang J, Kong X, Li J, Luo Q, Li X, Shen
L, Chen L and Fang L: miR-96 promotes tumor proliferation and
invasion by targeting RECK in breast cancer. Oncol Rep.
31:1357–1363. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guo H, Li Q, Li W, Zheng T, Zhao S and Liu
Z: MiR-96 downregulates RECK to promote growth and motility of
non-small cell lung cancer cells. Mol Cell Biochem. 390:155–160.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu S, Lu Z, Liu C, Meng Y, Ma Y, Zhao W,
Liu J, Yu J and Chen J: miRNA-96 suppresses KRAS and functions as a
tumor suppressor gene in pancreatic cancer. Cancer Res.
70:6015–6025. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Luo H, Li Y, Chen T, Wu S and Yang
L: hsa-miR-96 up-regulates MAP4K1 and IRS1 and may function as a
promising diagnostic marker in human bladder urothelial carcinomas.
Mol Med Rep. 5:260–265. 2012.PubMed/NCBI
|
|
14
|
Wu L, Pu X, Wang Q, Cao J, Xu F, Xu LI and
Li K: miR-96 induces cisplatin chemoresistance in non-small cell
lung cancer cells by downregulating SAMD9. Oncol Lett. 11:945–952.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin H, Dai T, Xiong H, Zhao X, Chen X, Yu
C, Li J, Wang X and Song L: Unregulated miR-96 induces cell
proliferation in human breast cancer by downregulating
transcriptional factor FOXO3a. PLoS One. 5:e157972010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Haflidadóttir BS, Larne O, Martin M,
Persson M, Edsjö A, Bjartell A and Ceder Y: Upregulation of miR-96
enhances cellular proliferation of prostate cancer cells through
FOXO1. PLoS One. 8:e724002013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bazzoni F, Rossato M, Fabbri M, Gaudiosi
D, Mirolo M, Mori L, Tamassia N, Mantovani A, Cassatella MA and
Locati M: Induction and regulatory function of miR-9 in human
monocytes and neutrophils exposed to proinflammatory signals. Proc
Natl Acad Sci USA. 106:5282–5287. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xie XQ, Zhao QH, Wang H and Gu KS:
Dysregulation of mRNA profile in cisplatin-resistant gastric cancer
cell line SGC7901. World J Gastroenterol. 23:1189–1202. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Machida S, Spangenburg EE and Booth FW:
Forkhead transcription factor FoxO1 transduces insulin-like growth
factor's signal to p27Kip1 in primary skeletal muscle satellite
cells. J Cell Physiol. 196:523–531. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu Z, Liu K, Wang Y, Xu Z, Meng J and Gu
S: Upregulation of microRNA-96 and its oncogenic functions by
targeting CDKN1A in bladder cancer. Cancer Cell Int. 15:1072015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang XL, Shi HJ, Wang JP, Tang HS, Wu YB,
Fang ZY, Cui SZ and Wang LT: MicroRNA-218 is upregulated in gastric
cancer after cytoreductive surgery and hyperthermic intraperitoneal
chemotherapy and increases chemosensitivity to cisplatin. World J
Gastroenterol. 20:11347–11355. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vishwamitra D, Li Y, Wilson D, Manshouri
R, Curry CV, Shi B, Tang XM, Sheehan AM, Wistuba II, Shi P and Amin
HM: MicroRNA 96 is a post-transcriptional suppressor of anaplastic
lymphoma kinase expression. Am J Pathol. 180:1772–1780. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hong Y, Liang H, Uzair-Ur-Rehman, Wang Y,
Zhang W, Zhou Y, Chen S, Yu M, Cui S, Liu M, et al: miR-96 promotes
cell proliferation, migration and invasion by targeting PTPN9 in
breast cancer. Sci Rep. 6:374212016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen RX, Xia YH, Xue TC and Ye SL:
Suppression of microRNA-96 expression inhibits the invasion of
hepatocellular carcinoma cells. Mol Med Rep. 5:800–804.
2012.PubMed/NCBI
|
|
26
|
Han S and Wei W: Camptothecin induces
apoptosis of human retinoblastoma cells via activation of FOXO1.
Curr Eye Res. 36:71–77. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang H, Regan KM, Lou Z, Chen J and
Tindall DJ: CDK2-dependent phosphorylation of FOXO1 as an apoptotic
response to DNA damage. Science. 314:294–297. 2006. View Article : Google Scholar : PubMed/NCBI
|
